Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
8.45
0.00 (0.00%)
At close: Mar 24, 2026, 4:00 PM EDT
8.61
+0.16 (1.89%)
After-hours: Mar 24, 2026, 6:05 PM EDT
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $456.63 million as of March 24, 2026. Its market cap has decreased by -4.70% in one year.
Market Cap
456.63M
Enterprise Value
85.62M
1-Year Change
-4.70%
Ranking
Category
Stock Price
$8.45
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $456.63M, an increase of 16.09%. That is a compound annual growth rate of 10.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 456.63M | -68.88% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADC Therapeutics | 490.39M |
| Verastem | 485.73M |
| enGene Holdings | 482.99M |
| Rigel Pharmaceuticals | 479.56M |
| Prothena Corporation | 471.04M |
| Larimar Therapeutics | 466.43M |
| Contineum Therapeutics | 455.87M |
| Assembly Biosciences | 451.45M |